Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-118852)

Filing Details

Accession Number:: 0001104659-21-118852
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-23 17:15:58
Reporting Period:: 2021-09-22

Accepted Time:: 2021-09-23 17:15:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1722964	Y-Mabs Therapeutics Inc.	YMAB	Pharmaceutical Preparations (2834)	474619612

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752940	Bo Kruse	C/O Y-Mabs Therapeutics, Inc. 230 Park Avenue Suite 3350 New York NY 10169	Evp, Cfo, Secretary & Treas.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-22	4,000	$30.82	221,077	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.